---
figid: PMC8220152__fcell-09-680100-g003
figtitle: 'Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive
  Niche Dialogue: New Perspectives and Therapeutic Potential'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Moloney murine leukemia virus
- NA
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Danio rerio
pmcid: PMC8220152
filename: fcell-09-680100-g003.jpg
figlink: /pmc/articles/PMC8220152/figure/F3/
number: F3
caption: DUB inhibitors and other inhibition methods performed to regulate the TAIM.
  Some inhibitors and other inhibition methods can block the upregulation of stemness-related
  signaling pathway components by DUBs. These processes weaken the function of CSCs
  during ITAIM creation through SRSs and possibly reverse the ITAIM. In addition,
  knocking out or knocking down some DUB genes can directly regulate the recruitment,
  quantity and function of immune cells in the TAIM. The red solid line represents
  the regulatory effect in the TAIM detected in preclinical trials, and the red dotted
  line represents the potential regulatory effect.
papertitle: 'Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive
  Niche Dialogue: New Perspectives and Therapeutic Potential.'
reftext: Jun-Nan Guo, et al. Front Cell Dev Biol. 2021;9:680100.
year: '2021'
doi: 10.3389/fcell.2021.680100
journal_title: Frontiers in Cell and Developmental Biology
journal_nlm_ta: Front Cell Dev Biol
publisher_name: Frontiers Media S.A.
keywords: deubiquitylating enzymes | deubiquitination | cancer stem cells | stemness-related
  signals | inhibitory tumor-associated immune microenvironment
automl_pathway: 0.9488053
figid_alias: PMC8220152__F3
figtype: Figure
redirect_from: /figures/PMC8220152__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8220152__fcell-09-680100-g003.html
  '@type': Dataset
  description: DUB inhibitors and other inhibition methods performed to regulate the
    TAIM. Some inhibitors and other inhibition methods can block the upregulation
    of stemness-related signaling pathway components by DUBs. These processes weaken
    the function of CSCs during ITAIM creation through SRSs and possibly reverse the
    ITAIM. In addition, knocking out or knocking down some DUB genes can directly
    regulate the recruitment, quantity and function of immune cells in the TAIM. The
    red solid line represents the regulatory effect in the TAIM detected in preclinical
    trials, and the red dotted line represents the potential regulatory effect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - USP14
  - USP7
  - MDM2
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - IK
  - DYRK3
  - FOXP3
  - CTNNB1
  - NFATC2
  - USP4
  - IL6
  - STAT3
  - TGFB1
  - TGFB2
  - TGFB3
  - USP15
  - CD274
  - BMI1
  - COMMD3-BMI1
  - USP22
  - NFKB1
  - TAM
  - STIM1
  - EPHB2
  - MAPK1
  - MAPK3
  - Wnt2
  - Usp14
  - Usp7
  - Mdm2
  - Notch1
  - Ik
  - Foxp3
  - Ctnnb1
  - Nfatc2
  - Usp4
  - Il6
  - Stat3
  - Tgfb1
  - Usp15
  - Bmi1
  - Usp22
  - Nfkb1
  - Ephb1
  - Hmgcr
  - Sap30l
  - Ltbp1
  - H2-T22
  - Cd274
  - Ephb2
  - Mapk1
  - usp14
  - usp7
  - mdm2
  - foxp3a
  - ctnnb1
  - nfatc2a
  - usp4
  - il6
  - stat3
  - ifnphi1
  - usp15
  - si:ch211-241b2.5
  - bmi1a
  - usp22
---
